BDSX Q1 2024 Earnings — Biodesix, Inc. Revenue & Financial Results | Market Cap Arena

BDSXBiodesix, Inc.

$151M

Q1 2024 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$15M+63.6% YoY

Gross Profit

$12M78.6% margin

Operating Income

-$11M-74.4% margin

Net Income

-$14M-91.9% margin

EPS (Diluted)

$-0.14

QoQ Revenue Growth

+1.0%

Cash Flow

Operating Cash Flow

-$15M

Free Cash Flow

-$16M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$87M

Total Liabilities

$93M

Stockholders' Equity

-$6M

Cash & Equivalents

$11M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$15M	$9M	+63.6%
Gross Profit	$12M	$6M	+97.8%
Operating Income	-$11M	-$16M	+32.7%
Net Income	-$14M	-$19M	+27.2%

Revenue Segments

Diagnostic Tests

$14M100%